chr1-170166622-T-C

Variant summary

Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate

The NM_001136107.2(NTMT2):ā€‹c.451T>Cā€‹(p.Phe151Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000419 in 1,551,846 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: š‘“ 0.000046 ( 0 hom., cov: 31)
Exomes š‘“: 0.000041 ( 0 hom. )

Consequence

NTMT2
NM_001136107.2 missense

Scores

7
5
7

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 7.64
Variant links:
Genes affected
NTMT2 (HGNC:31932): (N-terminal Xaa-Pro-Lys N-methyltransferase 2) Enables N-terminal protein N-methyltransferase activity. Involved in N-terminal protein amino acid methylation. Located in nucleus. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 4 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.853

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
NTMT2NM_001136107.2 linkuse as main transcriptc.451T>C p.Phe151Leu missense_variant 3/4 ENST00000439373.3 NP_001129579.1 Q5VVY1
NTMT2XM_011509232.3 linkuse as main transcriptc.256T>C p.Phe86Leu missense_variant 4/5 XP_011507534.1
NTMT2XM_011509233.3 linkuse as main transcriptc.256T>C p.Phe86Leu missense_variant 5/6 XP_011507535.1
NTMT2XM_011509234.3 linkuse as main transcriptc.256T>C p.Phe86Leu missense_variant 4/5 XP_011507536.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
NTMT2ENST00000439373.3 linkuse as main transcriptc.451T>C p.Phe151Leu missense_variant 3/41 NM_001136107.2 ENSP00000408058.3 Q5VVY1
NTMT2ENST00000367764.3 linkuse as main transcriptn.509T>C non_coding_transcript_exon_variant 4/55

Frequencies

GnomAD3 genomes
AF:
0.0000461
AC:
7
AN:
151926
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000103
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000505
AC:
8
AN:
158276
Hom.:
0
AF XY:
0.0000359
AC XY:
3
AN XY:
83514
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000121
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000811
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000414
AC:
58
AN:
1399920
Hom.:
0
Cov.:
37
AF XY:
0.0000391
AC XY:
27
AN XY:
690438
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.000112
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000500
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000461
AC:
7
AN:
151926
Hom.:
0
Cov.:
31
AF XY:
0.0000539
AC XY:
4
AN XY:
74210
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000103
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000175
Hom.:
0
Bravo
AF:
0.0000264

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJul 14, 2024The c.451T>C (p.F151L) alteration is located in exon 3 (coding exon 3) of the METTL11B gene. This alteration results from a T to C substitution at nucleotide position 451, causing the phenylalanine (F) at amino acid position 151 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.96
BayesDel_addAF
Benign
0.0023
T
BayesDel_noAF
Uncertain
0.0
CADD
Pathogenic
27
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.089
T
Eigen
Pathogenic
0.74
Eigen_PC
Pathogenic
0.71
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.88
D
M_CAP
Benign
0.020
T
MetaRNN
Pathogenic
0.85
D
MetaSVM
Benign
-1.0
T
MutationAssessor
Uncertain
2.4
M
PrimateAI
Uncertain
0.65
T
PROVEAN
Pathogenic
-6.0
D
REVEL
Uncertain
0.49
Sift
Benign
0.035
D
Sift4G
Benign
0.12
T
Polyphen
1.0
D
Vest4
0.80
MutPred
0.73
Loss of catalytic residue at F151 (P = 0.0278);
MVP
0.088
ClinPred
0.80
D
GERP RS
5.3
Varity_R
0.92
gMVP
0.75

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1458991957; hg19: chr1-170135763; API